Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Stascheit

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Der Nervenarzt|September 20, 2024
[Peripheral neuroimmunological diseases - Neuropathological insights and clinical perspectives]Sarah Hoffmann, Marie-Therese Holzer, Corinna Preuße, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2026
Aberrant Complement Activation Is a Prominent Feature of Chronic Inflammatory Demyelinating PolyneuropathyFrauke Stascheit, Hannah Preßler, Kerstin Stein, et al.
Frontiers in Neurology|January 30, 2023
Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case-Control studyFrauke Stascheit, Annette Aigner, Philipp Mergenthaler, et al.
Frontiers in Physiology|March 26, 2026
Cardiopulmonary exercise testing in mild generalized myasthenia gravis: an exploratory pilot feasibility studyFrauke Stascheit, Maximilian Lauermann, Lucie Risch, et al.
Journal of Neurology|February 29, 2024
Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient's perspectiveSophie Lehnerer, Meret Herdick, Regina Stegherr, et al.
Journal of Autoimmunity|April 18, 2026
Impact of a ketogenic diet on clinical outcomes and immunological markers in myasthenia gravis: A randomized pilot studyBenjamin Makus, Daniel Schulze, Sophie Lehnerer, et al.
Neuromuscular Disorders : NMD|February 6, 2023
Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravisSarah Hoffmann, Patrick Waters, Leslie Jacobson, et al.
Frontiers in Immunology|April 23, 2025
The burden of disease in seronegative myasthenia gravis: a patient-centered perspectiveSophie Lehnerer, Regina Stegherr, Ulrike Grittner, et al.
Journal of Neurology|November 20, 2021
Burden of disease in myasthenia gravis: taking the patient's perspectiveSophie Lehnerer, Jonas Jacobi, Ralph Schilling, et al.
European Journal of Neurology|November 14, 2025
AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and ControlsAmol K Bhandage, Sarah Hoffmann, Carla Dusemund, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Der Nervenarzt|September 20, 2024
[Peripheral neuroimmunological diseases - Neuropathological insights and clinical perspectives]Sarah Hoffmann, Marie-Therese Holzer, Corinna Preuße, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2026
Aberrant Complement Activation Is a Prominent Feature of Chronic Inflammatory Demyelinating PolyneuropathyFrauke Stascheit, Hannah Preßler, Kerstin Stein, et al.
Frontiers in Neurology|January 30, 2023
Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case-Control studyFrauke Stascheit, Annette Aigner, Philipp Mergenthaler, et al.
Frontiers in Physiology|March 26, 2026
Cardiopulmonary exercise testing in mild generalized myasthenia gravis: an exploratory pilot feasibility studyFrauke Stascheit, Maximilian Lauermann, Lucie Risch, et al.
Journal of Neurology|February 29, 2024
Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient's perspectiveSophie Lehnerer, Meret Herdick, Regina Stegherr, et al.
Journal of Autoimmunity|April 18, 2026
Impact of a ketogenic diet on clinical outcomes and immunological markers in myasthenia gravis: A randomized pilot studyBenjamin Makus, Daniel Schulze, Sophie Lehnerer, et al.
Neuromuscular Disorders : NMD|February 6, 2023
Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravisSarah Hoffmann, Patrick Waters, Leslie Jacobson, et al.
Frontiers in Immunology|April 23, 2025
The burden of disease in seronegative myasthenia gravis: a patient-centered perspectiveSophie Lehnerer, Regina Stegherr, Ulrike Grittner, et al.
Journal of Neurology|November 20, 2021
Burden of disease in myasthenia gravis: taking the patient's perspectiveSophie Lehnerer, Jonas Jacobi, Ralph Schilling, et al.
European Journal of Neurology|November 14, 2025
AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and ControlsAmol K Bhandage, Sarah Hoffmann, Carla Dusemund, et al.
Pageof 6